Chronic cardiorenal syndrome: cardio-renal protective effect of SGLT2i
SGLT2i provide a novel therapeutic strategy for chronic cardiorenal syndrome, with their multi-target mechanisms offering new perspectives for combined cardiorenal protection. However, further clinical research is required to optimize treatment protocols and address practical challenges in their application.
Authors
- Maojuan Guo (ORCID: https://orcid.org/0000-0002-2828-6050)
- Qian Lü (ORCID: https://orcid.org/0000-0003-2611-3284)
- Yixin Zhu (ORCID: https://orcid.org/0000-0003-4257-462X)
- Xuchen Wang (ORCID: https://orcid.org/0000-0002-5997-1130)
- Hanqi Yang (ORCID: https://orcid.org/0000-0002-0404-6685)
- Yueqi Zhang (ORCID: https://orcid.org/0000-0002-1189-2118)
- Chenxi Lv
- Bo Yang (ORCID: https://orcid.org/0000-0001-5586-3186)
Institutions
- Tianjin University of Traditional Chinese Medicine (CN)
- National Clinical Research (US)
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Renal Failure
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1080/0886022x.2025.2575921
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29